Senzar Asset Management as of June 30, 2018
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 24 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 18.8 | $6.5M | 107k | 60.70 | |
| Mylan Nv | 8.9 | $3.1M | 86k | 36.14 | |
| Sanofi-Aventis SA (SNY) | 8.8 | $3.1M | 77k | 40.01 | |
| CIGNA Corporation | 8.5 | $3.0M | 17k | 169.96 | |
| AstraZeneca (AZN) | 7.2 | $2.5M | 71k | 35.11 | |
| Regeneron Pharmaceuticals (REGN) | 5.2 | $1.8M | 5.2k | 345.02 | |
| Radius Health | 5.1 | $1.8M | 61k | 29.48 | |
| Gilead Sciences (GILD) | 4.5 | $1.6M | 22k | 70.85 | |
| CVS Caremark Corporation (CVS) | 4.5 | $1.6M | 24k | 64.36 | |
| Allergan | 4.2 | $1.5M | 8.7k | 166.69 | |
| Alder Biopharmaceuticals | 3.9 | $1.4M | 86k | 15.80 | |
| Anaptysbio Inc Common (ANAB) | 3.3 | $1.1M | 16k | 71.07 | |
| McKesson Corporation (MCK) | 2.9 | $1.0M | 7.5k | 133.47 | |
| Theravance Biopharma (TBPH) | 1.8 | $621k | 27k | 22.67 | |
| MiMedx (MDXG) | 1.6 | $543k | 85k | 6.38 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $534k | 5.4k | 98.43 | |
| Endologix | 1.5 | $517k | 91k | 5.66 | |
| Concert Pharmaceuticals I equity | 1.4 | $502k | 30k | 16.83 | |
| Arena Pharmaceuticals | 1.4 | $485k | 11k | 43.60 | |
| Tg Therapeutics (TGTX) | 1.2 | $415k | 32k | 13.14 | |
| Protagonist Therapeutics (PTGX) | 1.2 | $412k | 61k | 6.72 | |
| Foamix Pharmaceuticals | 1.0 | $338k | 67k | 5.01 | |
| United Therapeutics Corporation (UTHR) | 0.9 | $297k | 2.6k | 113.14 | |
| Prothena (PRTA) | 0.7 | $249k | 17k | 14.57 |
